News

EffRx attending the Jefferies Global Healthcare Conference 2026 in London,UK

November 16, 2026

EffRx attending the Jefferies Global Healthcare Conference 2026 in London,UK

EffRx will be attending the Jefferies Global Healthcare Conference 2026, taking place from November 16–19 at The Waldorf Hilton in London, UK.

Now in its 17th year, the conference is Europe’s largest healthcare-dedicated event, bringing together more than 800 leading public and private companies from across the biotechnology, biopharmaceutical, specialty pharmaceutical, medical technology, and healthcare services sectors.

As a major meeting point for the global healthcare industry, Jefferies 2026 will bring together industry leaders, investors, and innovators to exchange perspectives on market developments and explore new business opportunities. Through a combination of company presentations, networking sessions, and one-to-one meetings, the conference will provide a valuable platform for facilitating meaningful dialogue and exploring emerging industry trends.

At Jefferies 2026, EffRx will focus on identifying new M&A, in-licensing and strategic collaboration opportunities in Switzerland and across Europe, particularly in niche and specialty therapeutic areas, including rare diseases, endocrinology, metabolic and musculoskeletal disorders. We are particularly interested in late-stage and commercial-stage pharmaceutical assets with strong market potential, where a targeted commercialization strategy can create long-term value in Switzerland and other European markets.

Furthermore, EffRx is looking to establish partnerships for the commercialization of osteoporosis products in the US, Latin America, and selected Asian markets, including South Korea.

NON-CORP-1222-EN-v1